Subcutaneous biodegradable naltrexone implant and accompanying behavioral program for weight loss in a patient
AssigneeBiocorrx
InventorsLourdes Felix, Brady James Granier
Life of this patent
Estimating the term…
Abstract
Embodiments of the present disclosure provide methods, systems, and apparatuses for aiding weight loss in a patient. According embodiments, an exemplary system for aiding weight loss in a patent comprises a subcutaneous biodegradable medical implant placed or injected in the patient, the biodegradable medical implant comprising naltrexone (C20H23NO4) and capable of releasing the naltrexone from the subcutaneous biodegradable medical implant following the placement of the subcutaneous biodegradable medical implant in the patient; and an optional program comprising behavioral counseling and/or therapy delivered by a licensed professional to the patient.
Claims20
A subcutaneous biodegradable medical implant for aiding weight loss in a patient, the subcutaneous biodegradable medical implant comprising naltrexone (C20H23NO4), wherein subcutaneous biodegradable medical implant is capable of releasing a dosage amount of the naltrexone from the subcutaneous biodegradable medical implant following placement of the subcutaneous biodegradable medical implant in a patient, and wherein the naltrexone aids in weight loss of the patient.
A system for aiding weight loss in a patient, the system comprising:
- a subcutaneous biodegradable medical implant placed in the patient, the subcutaneous biodegradable medical implant comprising naltrexone (C20H23NO4) and capable of releasing a dosage amount of the naltrexone from the subcutaneous biodegradable medical implant following the placement of the subcutaneous biodegradable medical implant in the patient;
- and
- a program comprising behavioral counseling and/or therapy delivered by a licensed professional to the patient.
Dependencies are inferred from the claim text.